about
Vascular disease in cocaine addiction.Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarctionIn vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium.Attenuation correction for flexible magnetic resonance coils in combined magnetic resonance/positron emission tomography imaging.Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.Variations in atherosclerosis and remodeling patterns in aorta and carotids.Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE studyPrevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging.Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta.Feasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imagingMultimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.Imaging Macrophage and Hematopoietic Progenitor Proliferation in AtherosclerosisMultimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteriesPrednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.Feasibility of imaging superficial palmar arch using micro-ultrasound, 7T and 3T magnetic resonance imaging.Registration of dynamic contrast-enhanced MRI of the common carotid artery using a fixed-frame template-based squared-difference method.Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation.Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.Do carotid MR surface coils affect PET quantification in PET/MR imaging?Cap inflammation leads to higher plaque cap strain and lower cap stress: An MRI-PET/CT-based FSI modeling approach.Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression.Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque.Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.
P50
Q30235010-C5D2C35B-DFBA-4976-BBD4-46428CC7A335Q30436299-4BE36D2C-6C76-455C-8326-80F26DA4C87AQ30493876-61ECECC7-8460-4272-83F0-13EB4D2DBAE4Q30539291-BB763BC4-6640-4F40-905F-3ADB5CD06473Q30668738-FC6A0C8B-24DF-486C-84BE-8D2774997794Q33268808-9378EA75-A6F2-4C88-A663-2B772B06DF9EQ33624365-79F00928-F9B9-486B-A732-1CC25812C014Q33624371-D3254A9E-813F-4847-982C-540B6D2C31D7Q33678159-987F33DE-40D9-43A6-8FA6-D6760EE6D7E6Q33763488-5A8F17EB-EBE0-40B1-BB8F-84AC98D52A26Q33894213-99DC400A-E487-4B63-957E-32AA89890AD1Q33956714-870618BB-8007-4AE5-8505-C2B81F1DB8B3Q33994603-393FB1DB-0028-4ECB-822A-FD0DE030705DQ34746636-88663819-2F28-40D3-9AB9-5A1B22E7655BQ34982799-3BE4B049-87F2-4E34-A2A1-3D21B259B2A9Q35578295-E01FA89B-3A46-42F1-BC17-ABAF69DED77EQ35917109-4D4B8C56-7E31-4E6A-8921-320EF53538D6Q35929734-F240B768-B47D-4F0C-98C7-0FFED8C01D10Q35936550-6A251627-1D1E-4F86-8F73-47B21A69DEF1Q36013866-72FE7A3A-6582-4FD8-820E-F27DC4B864B5Q36202794-16801678-3BC0-43F7-BFFB-429F8DC05928Q36218239-F00E840E-4447-4862-862F-B9348CDCC9D0Q36223678-D8E5B089-0434-42AE-BC35-F1DA44B1F325Q36923150-67AA4F83-E3F0-4171-96B0-593D2982B736Q37188800-D88C3CDF-60F7-4607-9A5C-A3DA55048A5DQ37296851-3A20390A-92EF-4A62-B9F2-3C00970E979DQ37338935-07A2B5F2-72A8-4717-8DBA-31B530FB86A6Q37450201-0DB9938E-9C99-4B58-B583-78D6A347C5D7Q37678140-04C2C767-7D9F-45C8-90A2-7486E8A78B4DQ37720649-AAC69F9A-B213-4221-875A-CE7D3FC38EA5Q37763021-8C577870-2615-4820-A400-3E53016F1421Q37946008-633EB9FC-B02F-4573-9A82-AD2CC7F931CBQ38094125-F10C42CA-21F8-46A3-AA76-700FAEDE0C17Q38352448-1D8ED587-A24A-43C9-A34F-EEEBE7E67949Q38713992-7B95D4C1-1632-4F11-8CC6-1AB5D2343C88Q39179746-DD40015C-4FF2-4D86-A349-51B909DBC53BQ39185553-AAA6321D-5547-4E7E-9D99-AD51BD70A50DQ39293450-975F20AD-21A5-43C1-8CE5-B6706B0E20FEQ39296175-C83C982B-6748-41AC-B369-E9C780A95404Q39549749-C2816EA1-BF13-4533-A891-9E4A5711E4F8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Venkatesh Mani
@ast
Venkatesh Mani
@en
Venkatesh Mani
@es
Venkatesh Mani
@nl
Venkatesh Mani
@sl
type
label
Venkatesh Mani
@ast
Venkatesh Mani
@en
Venkatesh Mani
@es
Venkatesh Mani
@nl
Venkatesh Mani
@sl
prefLabel
Venkatesh Mani
@ast
Venkatesh Mani
@en
Venkatesh Mani
@es
Venkatesh Mani
@nl
Venkatesh Mani
@sl
P106
P1153
7006746701
P2456
P31
P3835
venkatesh-mani2
P496
0000-0002-0432-2918